A more in-depth look at news, policies and developments. Insights from both our in-house team of consultants in policy, public affairs, health economics and market access, as well as a roster of external experts with a wealth of knowledge and expertise.
The NHS Commercial Framework for New Medicines has been published. It aims to support patient access to affordable and transformative medicines. MAP provides insights into the effect it will have on the industry going forward.
Copyright © 2021. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52